These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

556 related articles for article (PubMed ID: 33233503)

  • 61. Diarrhea-predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations.
    Lacy BE; Moreau JC
    J Am Assoc Nurse Pract; 2016 Jul; 28(7):393-404. PubMed ID: 27436200
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice.
    Cao F; Tian X; Li Z; Lv Y; Han J; Zhuang R; Cheng B; Gong Y; Ying B; Jin S; Gao Y
    Front Pharmacol; 2020; 11():306. PubMed ID: 32265704
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increase in neurokinin-1 receptor-mediated colonic motor response in a rat model of irritable bowel syndrome.
    La JH; Kim TW; Sung TS; Kim HJ; Kim JY; Yang IS
    World J Gastroenterol; 2005 Jan; 11(2):237-41. PubMed ID: 15633223
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Eluxadoline benefits patients with irritable bowel syndrome with diarrhea in a phase 2 study.
    Dove LS; Lembo A; Randall CW; Fogel R; Andrae D; Davenport JM; McIntyre G; Almenoff JS; Covington PS
    Gastroenterology; 2013 Aug; 145(2):329-38.e1. PubMed ID: 23583433
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Involvement of shared mucosal-associated microbiota in the duodenum and rectum in diarrhea-predominant irritable bowel syndrome.
    Li G; Yang M; Jin Y; Li Y; Qian W; Xiong H; Song J; Hou X
    J Gastroenterol Hepatol; 2018 Jun; 33(6):1220-1226. PubMed ID: 29194775
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mucosal Tuft Cell Density Is Increased in Diarrhea-Predominant Irritable Bowel Syndrome Colonic Biopsies.
    Aigbologa J; Connolly M; Buckley JM; O'Malley D
    Front Psychiatry; 2020; 11():436. PubMed ID: 32477197
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Downregulation of mucosal mast cell activation and immune response in diarrhoea-irritable bowel syndrome by oral disodium cromoglycate: A pilot study.
    Lobo B; Ramos L; Martínez C; Guilarte M; González-Castro AM; Alonso-Cotoner C; Pigrau M; de Torres I; Rodiño-Janeiro BK; Salvo-Romero E; Fortea M; Pardo-Camacho C; Guagnozzi D; Azpiroz F; Santos J; Vicario M
    United European Gastroenterol J; 2017 Oct; 5(6):887-897. PubMed ID: 29026603
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy.
    Fusco R; Gugliandolo E; Biundo F; Campolo M; Di Paola R; Cuzzocrea S
    FASEB J; 2017 Aug; 31(8):3497-3511. PubMed ID: 28461340
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Tight junctions and IBS--the link between epithelial permeability, low-grade inflammation, and symptom generation?
    Piche T
    Neurogastroenterol Motil; 2014 Mar; 26(3):296-302. PubMed ID: 24548256
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Immune activation in patients with irritable bowel syndrome.
    Liebregts T; Adam B; Bredack C; Röth A; Heinzel S; Lester S; Downie-Doyle S; Smith E; Drew P; Talley NJ; Holtmann G
    Gastroenterology; 2007 Mar; 132(3):913-20. PubMed ID: 17383420
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Increased humoral immunity in the jejunum of diarrhoea-predominant irritable bowel syndrome associated with clinical manifestations.
    Vicario M; González-Castro AM; Martínez C; Lobo B; Pigrau M; Guilarte M; de Torres I; Mosquera JL; Fortea M; Sevillano-Aguilera C; Salvo-Romero E; Alonso C; Rodiño-Janeiro BK; Söderholm JD; Azpiroz F; Santos J
    Gut; 2015 Sep; 64(9):1379-88. PubMed ID: 25209656
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pro-inflammatory and anti-inflammatory cytokine response in diarrhoea-predominant irritable bowel syndrome patients.
    Rana SV; Sharma S; Sinha SK; Parsad KK; Malik A; Singh K
    Trop Gastroenterol; 2012; 33(4):251-6. PubMed ID: 23923350
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Changes in tight junction of intestinal mucosa in patients with irritable bowel syndrome: a study with tracing electron microscope].
    Kong WM; Gong J; Dong L; Chen MX
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1167-70, 1172. PubMed ID: 17715017
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Bertrand J; Ghouzali I; Guérin C; Bôle-Feysot C; Gouteux M; Déchelotte P; Ducrotté P; Coëffier M
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1170-1176. PubMed ID: 25972430
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Short-course therapy for diarrhea-predominant irritable bowel syndrome: understanding the mechanism, impact on gut microbiota, and safety and tolerability of rifaximin.
    Chang C
    Clin Exp Gastroenterol; 2018; 11():335-345. PubMed ID: 30288076
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alosetron versus traditional pharmacotherapy in clinical practice: effects on resource use, health-related quality of life, safety and symptom improvement in women with severe diarrhea-predominant irritable bowel syndrome.
    Olden KW; Chey WD; Shringarpure R; Paul Nicandro J; Chuang E; Earnest DL
    Curr Med Res Opin; 2019 Mar; 35(3):461-472. PubMed ID: 30293448
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Methamphetamine Induces Intestinal Inflammatory Injury via Nod-Like Receptor 3 Protein (NLRP3) Inflammasome Overexpression In Vitro and In Vivo.
    Zhao J; Shen S; Dai Y; Chen F; Wang K
    Med Sci Monit; 2019 Nov; 25():8515-8526. PubMed ID: 31712546
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The intestinal barrier in irritable bowel syndrome: subtype-specific effects of the systemic compartment in an in vitro model.
    Ludidi S; Jonkers D; Elamin E; Pieters HJ; Schaepkens E; Bours P; Kruimel J; Conchillo J; Masclee A
    PLoS One; 2015; 10(5):e0123498. PubMed ID: 25978614
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Altered expression of L-type calcium channel alpha1C and alpha1D subunits in colon of rats with diarrhea-predominant irritable bowel syndrome].
    Zhu J; Luo HS; Chen L; Zhou T
    Zhonghua Yi Xue Za Zhi; 2009 Oct; 89(38):2713-7. PubMed ID: 20137275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.